Member Info for TheYosh

From what I can tell, getting into the UK healthcare system will be the truly transformational news from here.

Already got the LOI for UK...

Basically urine tests for lung cancer are still in the research and development phase. At the moment it's CT scans and liquid biopsies (blood tests).

There are loads of liquid biopsy tests out there for lung cancer that the NHS are using including from Inivata, Synnovis, and Guardant Health (1000 times bigger company compared to Cizz) so we are late to the game.

If Cizz do get any form of partnership with the NHS (or a provider to the NHS) this year as per the LOI, then that will be a game changer for Cizz where reaching space is possible.

If the price goes down to about 2p again that'll be a good chance to buy more.

To be fair all predictions get lost in the ocean of uncertainty.

I've seen shares that should be £200mill market cap but are forever sat at £20mill, and I've seen shares with £100million market cap that should be £1billion yet never make it there.

This share should easily fit the range of £30mill - £50mill market cap considering similar company valuations and the agreements they already have, but this doesnt guarentee it'll get there, and also doesn't proclude some crazy overvaluation where a herd make it £150mill based on the NHS (indirect) collaboration. Cellbxhealth for example are double the value of cizzle with a form of liquid biopsy test but don't have the agreement/partnership/certainty strength that cizzle have.

Hi everyone, I used to follow this share, does anyone know the reason for the recent rise? (Or reason for the inital fall to 150p)?

Wish I'd bought at the cheaper price! Where will the price settle?

Does anyone remember NCYT going 100x near covid?

How do I post a link here?

https: //news.cancerresearchuk.org/2026/02/04/breaking-down-the-national-cancer-plan-for-england/

[LINK REMOVED]

[LINK REMOVED]